New gel treatment aims to save kidneys from cancer surgery
NCT ID NCT06822010
Summary
This study is testing a combination of two chemotherapy drugs, delivered directly into the kidney, to treat a specific type of upper urinary tract cancer. The main goal is to see if this approach can effectively control the cancer while allowing patients to keep their kidney, avoiding the standard surgery to remove it. About 28 adults with favorable, high-grade tumors that cannot be fully removed with a scope will participate to measure safety and how well the cancer responds.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.